HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER		Author Keyword(s) Vol Page [Advanced]

This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Email this link to a friend Similar articles in this journal Similar articles in PubMed Add article to my folders Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Mori, M Articles by Hattori, T Search for Related Content PubMed PubMed Citation Articles by Mori, M Articles by Hattori, T

Plasmapheresis and Miller Fisher syndrome: analysis of 50 consecutive cases

Department of Neurology, Chiba University School of Medicine 1-8-1, Inohana, Chuo-ku, Chiba, 260-8670 Japan;

Correspondence to:
Correspondence to:
Dr Mori,
morim@olive.ocn.ne.jp

Keywords: Miller Fisher syndrome; plasmapheresis; prognosis

Miller Fisher syndrome (MFS), characterised by the clinical triad of ataxia, ophthalmoplegia, and areflexia, is considered to be a variant form of Guillain-Barré syndrome (GBS). Large studies have shown that plasmapheresis¹ and immunoglobulin treatment² are beneficial for treating GBS. Because of the close relation between GBS and MFS, plasmapheresis may prove efficacious for treating MFS and has actually been tried in some cases. Moreover, because antibody to GQ1b is often present in serum from patients with MFS and is suggested to have a role in the pathophysiology of MFS, removing this antibody through plasmapheresis should have beneficial effects on patients with this syndrome. Although several reports have described possible plasmapheresis benefits in treating MFS,^3,4 none has compared its clinical effects in patients treated and not treated with plasmapheresis. We conducted a retrospective analysis of 50 consecutive patients with MFS to clarify whether plasmapheresis enhanced the speed of recovery.

Medical records . . . [Full text of this article]

This article has been cited by other articles:

				M. Mori, S. Kuwabara, T. Fukutake, and T. Hattori Intravenous immunoglobulin therapy for Miller Fisher syndrome Neurology, April 3, 2007; 68(14): 1144 - 1146. [Abstract] [Full Text] [PDF]